IBEX vs SOPH: stock comparison and AI forecast
Ibex Ltd (IBEX) and Sophia Genetics Sa (SOPH) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
IBEX Ibex Ltd
- Price
- $44.72 +60.2% · 6M
- Market Cap
- $594M
- P/E Ratio
- 14.3x
- Size
- small-cap
- AI Forecast
SOPH Sophia Genetics Sa
- Price
- $7.11 +34.4% · 6M
- Market Cap
- $605M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- IBEX and SOPH have similar market capitalizations ($594M and $605M).
- Over the last six months IBEX returned +60.2% and SOPH +34.4%.
- IBEX turns 7.2% of its revenue into net income, against -101.4% for SOPH.
- SOPH carries 2.46 times debt per unit of equity, against 0.82 times for IBEX.
- Both companies share the SEC industry classification Services-Computer Processing & Data Preparation.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | IBEX | SOPH |
|---|---|---|
| Market Cap | $594M | $605M |
| P/E Ratio | 14.29x | – |
| P/B Ratio | 3.49x | – |
| EPS | $3.13 | $-2.68 |
| Book Value/Share | $12.82 | – |
| Revenue/Share | $48.50 | $2.07 |
| FCF/Share | $2.35 | $-1.44 |
Profitability & Margins
| Metric | IBEX | SOPH |
|---|---|---|
| ROE | 27.2% | -379.9% |
| ROA | 15.0% | -109.9% |
| ROIC | 24.6% | -152.0% |
| Gross Margin | 29.2% | 67.4% |
| Operating Margin | 8.5% | -96.8% |
| Net Margin | 7.2% | -101.4% |
| EBT Margin | 8.4% | -99.4% |
| Tax Rate | 14.7% | -2.1% |
Financial Health
| Metric | IBEX | SOPH |
|---|---|---|
| Current Ratio | 2.10x | 1.96x |
| Quick Ratio | – | 1.84x |
| D/E Ratio | 0.82x | 2.46x |
| Financial Leverage | 1.82x | 3.46x |
| Interest Coverage | 44.2x | – |
| Working Capital | $94M | $49M |
Cash Flow
| Metric | IBEX | SOPH |
|---|---|---|
| Operating Cash Flow | $59M | -$122M |
| Free Cash Flow | $31M | -$123M |
| Capital Spending | -$28M | -$1M |
| OCF Growth YoY | 29.2% | – |
| FCF Growth YoY | 14.3% | – |
| FCF/Sales | 4.8% | -69.4% |
| CapEx/Sales | 4.3% | 0.6% |
Operational Efficiency
| Metric | IBEX | SOPH |
|---|---|---|
| Asset Turnover | 2.08x | 1.08x |
| Receivables Turnover | 5.1x | 11.8x |
| Inventory Turnover | – | 9.1x |
| Fixed Assets Turnover | 16.6x | 31.2x |
| Days Sales Outstanding | 71 days | 31 days |
| Days Inventory | – | 40 days |
Income Statement
| Metric | IBEX | SOPH |
|---|---|---|
| Total Revenue | $644M | $177M |
| Operating Income | $55M | -$171M |
| Net Income | $46M | -$179M |
| R&D Expense | – | $85M |
| SG&A Expense | $113M | – |
| Cost of Goods Sold | $456M | $58M |
Dividend & Shareholder Information
| Metric | IBEX | SOPH |
|---|---|---|
| Shares Outstanding | 13M | 85M |
| Net Income Growth | 25.7% | – |
| EPS Growth | 32.6% | – |
IBEX vs SOPH: stock comparison and AI forecast
Which is bigger, IBEX or SOPH?
IBEX and SOPH have similar market capitalizations ($594M and $605M).
Which stock performed better over the last six months, IBEX or SOPH?
Over the last six months IBEX returned +60.2% and SOPH +34.4%.
Which one does Intratio's AI model rank higher, IBEX or SOPH?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.